middl
east
respiratori
syndrom
coronaviru
merscov
infect
caus
sever
pneumonia
multiorgan
dysfunct
higher
crude
fatal
rate
around
vs
sar
coronaviru
sarscov
infect
understand
pathogenesi
studi
viral
replic
cytokinechemokin
respons
antigen
present
merscovinfect
human
monocytederiv
macrophag
mdm
versu
sarscovinfect
mdm
merscov
replic
mdm
virus
unabl
significantli
stimul
express
antivir
cytokin
interferon
induc
compar
level
tumor
necrosi
factor
interleukin
notabl
merscov
induc
significantli
higher
express
level
interleukin
chemokin
interleukin
sarscov
express
major
histocompat
complex
class
costimulatori
molecul
significantli
higher
merscovinfect
mdm
sarscovinfect
cell
merscov
replic
valid
immunostain
infect
mdm
ex
vivo
lung
tissu
conclus
show
merscov
establish
product
infect
human
macrophag
aberr
induct
inflammatori
cytokineschemokin
could
import
diseas
pathogenesi
septemb
novel
human
coronaviru
hcovemc
later
renam
middl
east
respiratori
syndrom
coronaviru
merscov
identifi
patient
sever
pneumonia
complic
renal
failur
travel
resid
saudi
arabia
retrospect
analysi
archiv
specimen
show
first
virolog
confirm
case
could
trace
back
earli
april
august
world
health
organ
confirm
case
infect
death
therefor
appal
fatal
rate
around
coronavirus
largest
rna
virus
posit
singlestrand
rna
genom
kb
mani
global
distribut
detect
wide
rang
anim
human
classifi
genera
alphacoronaviru
betacoronaviru
gammacoronaviru
deltacoronaviru
lineag
betacoronaviru
alphacoronaviru
known
caus
agent
common
cold
rare
caus
sever
respiratori
diseas
contrast
sar
coronaviru
sarscov
lineag
b
betacoronaviru
caus
sever
acut
respiratori
syndrom
sar
outbreak
affect
patient
countri
overal
fatal
rate
discoveri
sarscov
arous
grow
recognit
human
coronavirus
potenti
highli
pathogen
heighten
awar
spark
intens
hunt
novel
coronavirus
led
subsequ
identif
alphacoronaviru
lineag
betacoronaviru
occasion
caus
sever
lower
respiratori
tract
infect
young
children
elderli
individu
immunocompromis
patient
ten
year
sar
outbreak
anoth
novel
betacoronaviru
lineag
c
merscov
might
jump
speci
barrier
bat
human
caus
ongo
epidem
sever
human
infect
middl
east
patient
mer
present
rapidli
progress
pneumonia
mani
develop
multiorgan
dysfunct
derang
coagul
profil
hematolog
chang
includ
lymphopenia
neutrophilia
thrombocytopenia
although
clinic
syndrom
mer
resembl
describ
sever
sar
mer
often
renal
failur
substanti
surpass
sar
term
crude
fatal
rate
increas
number
persontoperson
transmiss
nosocomi
commun
set
grow
concern
anoth
sarslik
pandem
among
coronavirus
caus
human
infect
sarscov
extens
character
human
airway
epitheli
cell
primari
target
sarscov
howev
virusinfect
macrophag
contribut
significantli
diseas
pathogenesi
macrophag
sentinel
phagocyt
innat
immun
system
function
contain
elimin
pathogen
remov
apoptot
cell
present
antigen
cell
macrophageproduc
cytokin
chemokin
modul
immun
respons
erad
invad
pathogen
maintain
tissu
homeostasi
compar
human
primari
macrophag
peripher
blood
monocytederiv
macrophag
mdm
readili
avail
frequent
use
recapitul
initi
innat
immun
respons
macrophag
viral
infect
identif
merscov
sarscov
regard
danger
human
coronaviru
howev
higher
fatal
rate
sarscov
highlight
possibl
higher
pathogen
merscov
recent
studi
demonstr
similar
sarscov
merscov
capabl
infect
product
replic
primari
human
airway
epitheli
cell
ex
vivo
human
lung
tissu
furthermor
merscov
much
broader
tissu
tropism
sarscov
resembl
sarscov
abil
suppress
interferon
product
high
pathogen
merscov
prompt
us
explor
potenti
hostviru
interact
macrophag
cell
implic
pathogenesi
sar
therefor
studi
viral
infectionrepl
cellular
immun
respons
antigen
present
merscovinocul
mdm
comparison
sarscovinocul
mdm
understand
pathogenesi
mer
import
optim
treatment
strategi
highli
fatal
emerg
infecti
diseas
viru
cultur
viru
titrat
tissu
cultur
infect
dose
tcid
assay
clinic
isol
merscov
kindli
provid
fouchier
et
al
isol
cultur
vero
cell
atcc
serumfre
minimum
dulbecco
modifi
eagl
medium
dmem
life
technolog
supplement
uml
penicillin
streptomycin
co
sarscov
cultur
cell
atcc
medium
two
day
viru
inocul
cultur
supernat
collect
store
freezer
aliquot
viru
titrat
aliquot
merscov
sarscov
appli
confluent
vero
cell
plate
assay
briefli
serial
dilut
viru
inocul
vero
cell
monolay
sextuplet
cultur
penicillinstreptomycinsuppl
dmem
plate
observ
cytopath
effect
day
viral
titer
calcul
reed
end
point
method
one
tcid
interpret
amount
viru
caus
cytopath
effect
inocul
well
healthi
adult
blood
sampl
collect
hong
kong
red
cross
blood
transfus
servic
accord
protocol
approv
institut
review
board
univers
hong
kong
monocyt
prepar
differenti
perform
accord
wellestablish
protocol
describ
previous
puriti
macrophag
assess
flow
cytometri
analysi
averag
viral
infect
mdm
plate
inocul
merscov
sarscov
tcid
cell
mock
inocul
hour
supernat
cell
lysat
harvest
hour
infect
tcid
assay
perform
cellfre
supernat
viral
titrat
cell
lysat
extract
rna
detect
viral
rna
cellular
messeng
rna
mrna
immunostain
mdm
seed
plate
glass
coverslip
cell
inocul
merscov
tcid
cell
twelv
hour
infect
cell
fix
paraformaldehyd
immunostain
quantif
viral
cellular
rna
transcript
reversetranscript
quantit
polymeras
chain
reaction
rtqpcr
cellular
rna
extract
rtqpcr
perform
describ
previous
viral
rna
supernat
extract
purelink
viral
rnadna
mini
kit
life
technolog
virusspecif
primer
merscov
sarscov
use
revers
transcript
gener
complementari
dna
cdna
virus
oligo
dt
cellular
cdna
specif
primer
use
qpcr
analysi
list
supplementari
tabl
cellular
gene
express
result
normal
gapdh
present
fold
chang
gene
express
virusinfect
mdm
rel
mockinfect
cell
ex
vivo
lung
tissu
cultur
viru
infect
experi
approv
institut
review
board
univers
hong
konghospit
author
hong
kong
west
cluster
fresh
normal
lung
tissu
obtain
patient
undergo
resect
lung
tumor
lung
tissu
cut
cube
subsequ
infect
merscov
inoculum
tcid
ml
mockinfect
hour
inocul
tissu
cube
maintain
medium
supplement
human
serum
penicillinstreptomycin
fixat
cryosect
describ
previous
merscov
detect
use
previous
describ
guinea
pig
antinucleocapsid
protein
np
antibodi
hour
room
temperatur
follow
fluorescein
isothiocyanateconjug
rabbitantiguinea
pig
immunoglobulin
g
igg
life
technolog
alexa
goatantiguinea
pig
igg
abcam
secondari
antibodi
tissu
slide
macrophag
label
mous
antibodi
abcam
follow
alexa
goatantimous
igg
abcam
primari
secondari
antibodi
dilut
final
slide
mount
prolong
gold
antifad
reagent
life
technolog
examin
carl
zeiss
lsm
microscop
experiment
result
repres
mean
standard
error
mean
least
differ
donor
statist
comparison
group
perform
student
test
use
graphpad
prism
differ
consid
statist
signific
p
valu
understand
abil
merscov
infect
human
macrophag
inocul
mdm
merscov
sarscov
parallel
observ
outcom
infect
examin
level
viral
gene
cell
lysat
cultur
supernat
shown
figur
level
merscov
rna
increas
hour
infect
cell
lysat
figur
supernat
figur
mdm
despit
variat
among
differ
donor
increas
viral
rna
level
consist
detect
merscov
infect
replic
mdm
confirm
tcid
assay
increas
titer
infecti
viru
observ
inocul
contrari
dose
sarscov
inocul
onto
mdm
sign
viral
replic
observ
viral
rna
level
gradual
decreas
cell
lysat
cultur
supernat
infecti
virus
detect
supernat
sarscovinfect
mdm
remain
low
level
indic
abort
infect
replic
merscov
mdm
verifi
immunofluoresc
studi
shown
figur
strong
fluoresc
signal
merscov
np
observ
cytoplasm
virusinocul
mdm
twelv
hour
infect
infect
cell
display
punctalik
posit
cytoplasm
wherea
hour
infect
cell
display
homogen
immunoreact
np
throughout
cytoplasm
moreov
npposit
cell
hour
infect
hour
infect
data
shown
compat
product
infect
replic
mockinfect
mdm
display
immunoreact
np
moreov
replac
antinp
sera
preimmun
sera
yield
posit
signal
infect
mdm
data
shown
collect
demonstr
infect
replic
capabl
merscov
mdm
next
assess
cell
viabil
merscovinfect
sarscovinfect
mockinfect
mdm
calcul
number
viabl
cell
hour
infect
compar
data
valu
obtain
right
infect
shown
approxim
mockinfect
mdm
remain
viabl
hour
infect
wherea
percentag
viabl
cell
among
merscovinfect
mdm
significantli
reduc
figur
contrast
compar
mock
infect
sarscov
appear
protect
effect
cell
death
differ
howev
statist
signific
result
suggest
merscov
induc
significantli
higher
cytotox
sarscov
infect
mdm
evalu
respons
mdm
activ
merscov
replic
assess
mrna
express
level
seri
antivir
cytokin
proinflammatori
cytokin
chemokin
merscovinfect
sarscovinfect
mock
figur
merscovinfect
sarscovinfect
mdm
display
fairli
weak
compar
express
level
wherea
ifn
highli
induc
influenza
infect
mdm
data
shown
howev
express
highli
induc
virus
induct
promin
merscovinocul
mdm
sarscovinocul
cell
compar
induc
merscovinfect
sarscovinfect
cell
significantli
induc
merscov
sarscov
consist
high
induct
protein
secret
varieti
cell
respons
highli
upregul
virus
significantli
induc
merscovinfect
cell
figur
chemokin
extens
studi
implic
immunopathogen
sarscov
data
demonstr
merscov
induc
significantli
higher
level
compar
sarscov
mdm
studi
agreement
previou
report
collect
found
similar
sarscov
merscov
unabl
induc
effect
antivir
ifn
respons
virus
similarli
upregul
express
merscov
induc
express
remark
merscov
profoundli
sustain
induc
immun
cellrecruit
chemokin
cytokin
mdm
merscov
modestli
upregul
express
mhc
class
irel
molecul
hlaa
hlab
mhc
class
iirel
gene
merscov
fail
induc
express
hladmb
upregul
express
addit
merscov
significantli
induc
higher
level
express
sarscov
figur
summari
data
suggest
merscov
trigger
higher
express
mhc
class
mhc
class
ii
costimulationrel
gene
mdm
sarscov
although
mdm
product
infect
vitro
fulli
repres
scenario
real
merscov
infect
end
perform
merscov
inocul
ex
vivo
cultur
human
lung
tissu
macrophag
abund
found
airway
epitheli
cell
predominantli
pneumocyt
epitheli
cell
termin
bronchiol
infect
base
cell
tissu
morpholog
figur
moreov
intens
immunoreact
merscov
np
observ
endotheli
cell
blood
vessel
interstitia
figur
specif
defin
npposit
cell
costain
epitheli
celland
endotheli
cellspecif
marker
focu
studi
stark
contrast
recent
studi
found
lung
macrophag
infect
merscov
shown
coloc
merscov
np
figur
although
fluoresc
intens
np
stronger
respiratori
epitheli
cell
macrophag
coloc
np
mockinfect
tissu
figur
basi
observ
demonstr
human
lung
macrophag
suscept
merscov
infect
ex
vivo
studi
aim
elucid
pathogenesi
merscov
first
found
vascular
endotheli
cell
pulmonari
interstitium
macrophag
could
infect
merscov
figur
corrobor
clinic
observ
viru
system
dissemin
patient
mer
recent
studi
describ
patient
mer
develop
rapidli
progress
pneumonia
respiratori
failur
acut
renal
failur
septic
shock
eventu
die
patient
high
level
viral
rna
transcript
bronchoalveolar
lavag
fluid
patient
urin
stool
sampl
also
posit
viral
rna
despit
neg
result
merscov
blood
sampl
patient
anoth
studi
verifi
presenc
viral
rna
transcript
whole
blood
patient
mer
accord
gene
express
profil
normal
human
tissu
public
databas
merscov
receptor
abundantli
express
varieti
human
cell
tissu
may
facilit
viral
dissemin
previou
studi
also
provid
strong
evid
cell
deriv
mani
human
tissu
support
merscov
infect
replic
present
find
may
provid
direct
patholog
basi
system
viru
dissemin
mer
second
immun
cellrecruit
cytokineschemokin
highli
endur
induc
mdm
upon
merscov
infect
figur
addit
proinflammatori
cytokin
also
contribut
chemoattract
cascad
might
lead
larg
number
immun
cell
infiltr
patient
lower
respiratori
tract
caus
sever
inflamm
tissu
damag
clinic
patient
mer
present
rapidli
progress
pneumonia
multilobar
consolid
radiograph
comput
tomographi
scan
cytolog
examin
bronchoalveolar
lavag
fluid
often
show
high
number
neutrophil
macrophag
merscovinocul
rhesu
macaqu
display
milder
respiratori
symptom
patient
mer
histopatholog
examin
lung
tissu
show
acut
pneumonia
infiltr
neutrophil
macrophag
believ
cytokinechemokin
induct
may
respons
infiltr
immun
cell
substanti
contribut
sever
pneumonia
respiratori
dysfunct
patient
mer
furthermor
patient
mer
develop
lymphopenia
cours
infect
clinic
manifest
attribut
immun
cell
recruit
sequestr
lower
respiratori
tract
trigger
cytokinechemokin
induct
addit
found
suppress
prolifer
human
myeloid
progenitor
cell
highli
induc
upon
merscov
infect
induct
chemokin
may
inevit
aggrav
lymphopenia
patient
mer
taken
togeth
experiment
find
compat
patient
clinic
present
also
elucid
pathogen
mechan
lifethreaten
diseas
compar
merscov
sarscov
aspect
viral
replic
cytokinechemokin
product
antigen
present
mdm
well
recogn
sarscov
infect
mdm
abort
unlik
abort
infect
sarscov
mdm
merscov
establish
product
infect
mdm
figur
decreas
viral
titer
donor
hour
viru
inocul
may
due
excess
cell
death
time
infect
merscov
human
macrophag
substanti
presenc
viral
np
macrophag
virusinocul
ex
vivo
lung
tissu
figur
macrophag
among
first
line
host
defens
viral
invas
effici
viral
replic
cell
implic
viru
overcom
host
defens
highli
virul
product
viral
replic
macrophag
may
turn
phagocyt
viral
reservoir
vehicl
replic
dissemin
shown
human
immunodefici
viru
respons
viral
infect
macrophag
secret
proinflammatori
cytokineschemokin
activ
variou
antivir
mechan
howev
direct
infect
immun
cell
viru
may
caus
dysregul
induct
inflammatori
mediat
could
damag
neighbor
tissu
among
proinflammatori
mediat
aberr
induct
almost
hallmark
sever
respiratori
viral
infect
sar
human
infect
avian
influenza
virus
immunostimulatori
effect
outweigh
antivir
effect
sar
function
stimul
growth
activ
cell
natur
killer
nk
cell
induc
product
proinflammatori
cytokin
cell
notabl
strong
chemoattract
monocytesmacrophag
cell
nk
cell
acut
inflammatori
cell
site
infect
apart
chemotact
effect
granulocyt
cell
rant
also
promot
tcell
nkcell
activ
show
strong
chemotaxi
neutrophil
granulocyt
also
potent
induc
chemokin
number
studi
indic
antivir
ifn
cytokin
induc
sarscovinfect
macrophag
dendrit
cell
possibl
sarscov
evolv
strategi
antagon
innat
respons
contrast
proinflammatori
cytokin
chemokin
upregul
plethora
clinic
studi
report
level
proinflammatori
cytokineschemokin
includ
highli
elev
patient
sar
correl
diseas
sever
mortal
addit
macrophag
patient
lung
tissu
believ
produc
cytokin
storm
underli
pathogenesi
sar
compar
found
mani
cytokineschemokin
merscovinfect
mdm
share
similar
express
profil
sarscovinfect
cell
notabl
immun
cellrecruit
chemokin
immunostimul
cytokin
induc
significantli
higher
magnitud
prolong
interv
merscov
compar
sarscov
therefor
conceiv
immunopathogenesi
oper
sar
may
aggrav
mer
caus
sever
diseas
higher
fatal
detail
express
profil
cytokinechemokin
respons
merscovinfect
sarscovinfect
mdm
investig
microarray
analysi
express
mhc
class
mhc
class
ii
costimulationrel
gene
modestli
induc
merscovinfect
mdm
margin
stronger
sarscovinfect
cell
figur
contrast
recent
report
show
decreas
antigenpresent
profil
merscovinfect
lung
cancer
cell
line
disagr
possibl
attribut
differ
properti
mdm
lung
cancer
cell
line
full
scenario
antigen
present
mer
definit
warrant
investig
nevertheless
base
result
increas
antigen
present
merscovinfect
mdm
may
potenti
contribut
exagger
immunopatholog
taken
togeth
demonstr
merscov
infect
effect
replic
mdm
merscov
replic
mdm
caus
extens
cytotox
induc
express
number
proinflammatori
cytokineschemokin
mixtur
high
viral
replic
immunemedi
patholog
could
import
factor
pathogenesi
mer
supplementari
materi
avail
journal
infecti
diseas
onlin
http
jidoxfordjournalsorg
supplementari
materi
consist
data
provid
author
publish
benefit
reader
post
materi
copyedit
content
supplementari
data
sole
respons
author
question
messag
regard
error
address
author
